Frequency Of Hepatitis D Co/ Super Infection In Hepatitis B Patients

Authors: Altaf Hussain Shaikh Javed Ahmed Phulpoto

GHULAM MOHAMMED MEDICAL COLLEGE SUKKUR.
GHULAM MOHAMMED MEDICAL COLLEGE SUKKUR.

Volume 16 | Issue 4

Published: November 10, 2026

Abstract

To determine the frequency of co/ super infection of hepatitis D in patients
with hepatitis B related liver disorders. MATERIALS & METHODS: This prospective descriptive study was conducted at Ghulam Mohammed Medical College Sukker during September 2008 - December 2009. After obtaining informed consent patients diagnosed with HBV associated infection were enrolled in the study. Blood sample was obtained from 223 patients who satisfied the inclusion criteria. Patients with an incomplete test profile were excluded. All baseline investigations were obtaining in addition to liver function tests, coagulation profile, abdominal ultrasonography, upper gastrointestinal endoscopy and liver biopsy. The diagnosis of liver cirrhosis and hepatocellular carcinoma (HCC) were established either on the base of histopathology, or on in addition to radiological, endoscopic and laboratory data. Hepatitis B virus DNA was extracted from serum by real time PCR. Statistical analysis was done through SPSS 17. Descriptive statistics were used for frequency and mean determination. RESULTS: Out of 223 patients, 148 patients finally selected for statistical analysis included 116 (78.37%) males and 32 (21.62%) females. The ages ranged from 11- 63 years. There were 78 (52.70%) patients of non-cirrhotic, chronic hepatitis (CLD), 43 (29.05%) carriers, 16 (10.81%) cirrhotics and 11 (7.43%) Hepatocellular carcinoma (HCC) patients. Among the 148 patients, 58 (39.18%) were positive for double infection with HDV. These included 41 CLD cases, 11 cirrhotic and 5 carriers. CONCLUSION: The frequency of co/ super infection of hepatitis D were highest in HBV cirrhosis patients as compared with patients having chronic liver disease (non-cirrhotics) and carriers.

Keywords: Hepatitis D virus co/ super infection, Hepatitis B virus, Cirrhosis, Chronic liver disease.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF